Palliative Care Market (By Condition: Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease, Others; By Diagnostic Group: Communicable diseases, Non-communicable diseases, Injury, poisoning, external causes, Maternal, perinatal, and nutritional conditions; By Age Group: Pediatric, Adult, Geriatric; By Provider: Hospitals and Clinics, Home-based, Community Settings) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034
The global palliative care market size was USD 126.09 billion in 2023, accounted for USD 138.83 billion in 2024, and is expected to reach around USD 363.36 billion by 2034, expanding at a CAGR of 9% from 2024 to 2034. Increasing senior population, non-communicable, communicable diseases, and other serious diseases lead to the growth of the market.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The Europe palliative care market size was estimated at USD 47.91 billion in 2023 and is predicted to be worth around USD 138.08 billion by 2034, at a CAGR of 9.2% from 2024 to 2034.
Europe held the largest share of 38% in the palliative care market in 2023. Many European countries have prioritized palliative care as an essential component of healthcare policy, with governments providing substantial funding and support for palliative care initiatives. National healthcare systems and insurance schemes often cover palliative care services, ensuring affordability and accessibility for patients and their families. European palliative care providers adopt a multidisciplinary approach to patient care, involving interdisciplinary teams of physicians, nurses, social workers, psychologists, and other healthcare professionals. This holistic approach addresses the physical, emotional, social, and spiritual needs of patients and their families, enhancing the quality of life and overall well-being of individuals receiving palliative care.
North America held a notable share of the palliative care market in 2023. Palliative care may be available for everyone who needs it in any case of diagnosis, age, or region. The increasing senior population leads to the demand for hospice and palliative care in the North American region. In the United States, the palliative care field is increasing rapidly. The benefits of palliative care shown in several clinical trials are increased satisfaction, the ability to choose the place of death, less depression and anxiety, and cost-saving factors that help the growth of the market in this region. If some patient needs special services, healthcare providers may refer other specialists and providers like the Canadian Hospice Palliative Care Association, which provides hospice and palliative care services; the Government of Canada gives caregiving benefits and leaves, and Canadian Virtual Hospice gives palliative care services for the quality of life.
Asia Pacific is estimated to be the fastest-growing region during the forecast period of 2024-2034. Countries like Japan have an old population that needs palliative care due to the natural occurrence of prolonged diseases. A non-profit organization, Asia Pacific Hospice Palliative Care Network, is advancing hospice and palliative care in the Asia Pacific region. This organization aims to support patients who are suffering from life-threatening conditions.
Palliative care is to improve the quality of life of patients like adults and children and their families who are facing problems with life-threatening long-term illnesses. The palliative care market deals with all required needs for palliative care, including medicines, monitoring equipment, laboratories, healthcare professionals, nurses, etc. Palliative care demand increases due to an increase in serious illnesses like chronic diseases, heart failure, neurogenerative conditions, HIV and AIDS, cancers, and multiple sclerosis. Palliative care helps improve the quality of life of seriously ill patients and comforts the families of the patients. Palliative care facilities can be in various locations like at home, hospitals, outpatient clinics, nursing homes, and assisted living facilities. Some patients take their treatments at home with the help of palliative care. Palliative care also helps to provide emotional, spiritual, and social support. It also helps to provide support and information on healthcare costs and advanced healthcare planning.
Report Coverage | Details |
Growth Rate from 2024 to 2034 | CAGR of 9% |
Global Market Size in 2023 | USD 126.09 Billion |
Global Market Size in 2024 | USD 138.83 Billion |
Global Market Size by 2034 | USD 363.36 Billion |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2034 |
Segments Covered | By Condition, By Diagnostic Group, By Age Group, and By Provider |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Palliative care has many benefits for various life-threatening conditions. Some common conditions where palliative care is helpful include cancer, chronic obstructive pulmonary disease (COPD), dementia, and cardiovascular diseases. Cancer is a common illness that needs palliative care market. Palliative cancer care is helpful depending on the type of cancer, age, prognosis, treatment, and segments. Palliative cancer care is also helpful for managing the side effects of radiation and chemotherapy and for recovering patients after surgery. It also includes treatments for depression and anxiety.
According to the World Health Organization (WHO), palliative care can be used for patients who are suffering from cardiovascular diseases. Palliative care for cardiovascular disease can help with mental health support, decision-making support, and symptom relief. Dementia is linked with a breakdown of brain functions. Palliative care may be helpful for the treatment of dementia, which causes anxiety. The market is also significant in managing a respiratory illness, chronic obstructive pulmonary disease, that causes shortness of breath and coughing. This also includes treatments for anxiety and discomfort linked with breathing difficulty.
National health systems and policies rarely use palliative care facilities. Training for healthcare professionals in palliative care is non-existent or limited. Healthcare professionals’ mistrust and confusion about misperceptions and terminologies. Fear in healthcare professionals of palliative care may deny life-prolonging therapies to patients. Hospital inpatients face multiple problems with accessing palliative care. Palliative care specialists are not experienced, as there is a lack of specialized knowledge for the treatment of palliative care. These factors may restrict the growth of the palliative care market. It makes the burden of decision-making and discomfort with end-of-life issues an emotional challenge, which may lead to avoidance of palliative care.
For the market, future perspectives are health-promoting palliative care and public palliative care. It may provide directions and ideas for the development of palliative care in all sectors globally. Collaboration between healthcare and public services makes it possible to provide palliative care in the future for everyone who is in need. Strong action is required for the translation of palliative care and plans, which includes competent management, political support, and strong leadership.
Information campaigns and public education are helpful in changing public attitudes toward palliative care. Education campaigns and activities of “World Hospice and Palliative Care Day” would help to increase awareness among the people. Healthcare professionals in palliative care must be well-trained. The standards for palliative care must be developed with a large number of contributions from stakeholders to the attainment of minimum service requirements.
The cancer segment dominated the palliative care market in 2023. Cancer treatments have side effects, and they may remain for a year even after treatment is completed. Palliative care eases the treatment side effects, and cancer treatments many people get an advantage from it. Cancer is the most common condition linked with palliative care. Palliative cancer care depends upon symptoms, type of cancer, prognosis, age, and treatment. A cancer diagnosis may get palliative care for managing the side effects of radiation, chemotherapy, and recovering patients after surgery. For treating anxiety and depression, palliative cancer care is helpful and also a helpful tool for their family members for future healthcare planning.
The respiratory disease segment is the fastest growing during the forecast period. The palliative care market may help manage respiratory diseases like chronic obstructive pulmonary disease (COPD), which causes breath shortening and coughing. Palliative care may also include treatment for anxiety and discomfort linked with breathing difficulty. Changing lifestyles, including smoking, may improve illness related to respiratory diseases; in that case, palliative care is helpful.
The non-communicable diseases segment dominated the palliative care market in 2023. Non-communicable diseases can benefit from palliated care, which is linked to health-related conditions. Non-communicable diseases include diabetes, cancers, cardiovascular diseases, and others, and these long-term diseases need palliative care. Many individuals suffer from non-communicable diseases, mainly cancers, and there is a demand for palliative care. For improving health systems, particularly non-communicable diseases, the use of palliative care has increased.
The maternal, perinatal, and nutritional conditions (MPNC) segment is the fastest growing during the forecast period. During maternal fatal conditions, palliative care is preferred. The palliative care market may help in the balancing of fatal medicine's ethical concerns. Palliative care teams help to support families and healthcare professionals or physicians in approaching goal-oriented care in maternal, neonatal, and fatal management conclusions with a fatal diagnosis. Palliative care teams can help to comfort care approaches and support termination and fatal interventions.
Perinatal palliative care introduces interrelated care plans that include obstetric and newborn care, which involve a focus on comfort for newborns and maximizing the quality of life. Perinatal palliative care may provide life-prolonging treatment. Palliative care is helpful for nutritional conditions, such as dietary advice for timely nutritional support and decreased diet-related issues. Palliative care is not only for treating or preventing nutritional conditions but also for improving comfort, quality of life, enjoyment of food, and symptom relief.
The adult segment dominated the market in 2023. Adult palliative care services increased due to the increase in diseases among this population. As the number of adult groups increases, there is an increase in chronic diseases like cancer, diabetes, cardiovascular disease, and so on that need palliative care for adults. Healthcare professionals refer to palliative care consultations for adult patients. In adult palliative care, these are patient-centered, and the relatives are involved as representatives for decision-making.
The pediatric segment is growing at the fastest rate. A classification for life-threatening diseases in different countries with different incomes is proposed by the Royal College of Pediatrics and Childcare. They may need pediatric palliative services. Pediatric palliative care is child and family centered. The number of patients who are suffering from chronic, life-limiting, and complex conditions and their family’s pediatric palliative care demand increases.
The home-based segment dominated the market in 2023. Home-based palliative care is a service that provides social and medical support to patients with serious conditions and their caregivers at their homes. Home-based palliative care may help caregivers and patients create plans to manage symptoms and care, make medical decisions based on values, understand the illness and prognosis, assess the need for additional help, and associate with resources. Benefits of home-based palliative care for patients, families, and health systems and its result on improved resource utilization and cost-savings. As compared to normal care, home-based palliative care lowers the cost and utilization of resources for cancer, non-cancer, high-risk elderly, COPD populations, and heart failures.
The hospitals and clinics segment is observed to be the fastest growing during the forecast period. Palliative care may be provided in the hospital setting, including professional palliative care units. Hospital-based palliative care includes palliative care units, ambulatory palliative care services, and palliative care consult teams. Outpatient clinics are committed to outpatient palliative care clinics that offer help to patients outside of hospital settings.
Segments Covered in the Report
By Condition
By Diagnostic Group
By Age Group
By Provider
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Palliative Care Market
5.1. COVID-19 Landscape: Palliative Care Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Palliative Care Market, By Condition
8.1. Palliative Care Market, by Condition, 2024-2034
8.1.1. Cancer
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Dementia
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. HIV
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Cerebrovascular Disease
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Respiratory Disease
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Palliative Care Market, By Diagnostic Group
9.1. Palliative Care Market, by Diagnostic Group, 2024-2034
9.1.1. Communicable diseases
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Non-communicable diseases
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Injury, poisoning, external causes
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Maternal, perinatal, and nutritional conditions
9.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Palliative Care Market, By Age Group
10.1. Palliative Care Market, by Age Group, 2024-2034
10.1.1. Pediatric
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Adult
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Geriatric
10.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Palliative Care Market, By Provider
11.1. Palliative Care Market, by Provider, 2024-2034
11.1.1. Hospitals and Clinics
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Home-based
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Community Settings
11.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 12. Global Palliative Care Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Condition (2021-2034)
12.1.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.1.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.1.4. Market Revenue and Forecast, by Provider (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Condition (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.1.5.4. Market Revenue and Forecast, by Provider (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Condition (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.1.6.4. Market Revenue and Forecast, by Provider (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Condition (2021-2034)
12.2.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.2.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.2.4. Market Revenue and Forecast, by Provider (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Condition (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.2.5.4. Market Revenue and Forecast, by Provider (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Condition (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.2.6.4. Market Revenue and Forecast, by Provider (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Condition (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.2.7.4. Market Revenue and Forecast, by Provider (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Condition (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.2.8.4. Market Revenue and Forecast, by Provider (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Condition (2021-2034)
12.3.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.3.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.3.4. Market Revenue and Forecast, by Provider (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Condition (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.3.5.4. Market Revenue and Forecast, by Provider (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Condition (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.3.6.4. Market Revenue and Forecast, by Provider (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Condition (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.3.7.4. Market Revenue and Forecast, by Provider (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Condition (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.3.8.4. Market Revenue and Forecast, by Provider (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Condition (2021-2034)
12.4.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.4.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.4.4. Market Revenue and Forecast, by Provider (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Condition (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.4.5.4. Market Revenue and Forecast, by Provider (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Condition (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.4.6.4. Market Revenue and Forecast, by Provider (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Condition (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.4.7.4. Market Revenue and Forecast, by Provider (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Condition (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.4.8.4. Market Revenue and Forecast, by Provider (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Condition (2021-2034)
12.5.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.5.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.5.4. Market Revenue and Forecast, by Provider (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Condition (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.5.5.4. Market Revenue and Forecast, by Provider (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Condition (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Diagnostic Group (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.5.6.4. Market Revenue and Forecast, by Provider (2021-2034)
Chapter 13. Company Profiles
13.1. Teresa Dellar Palliative Care Residence
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Amedisys
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Banksia Palliative Care Service Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Adventist Health
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Alpha Palliative Care
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Baptist Health
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Genesis HealthCare System
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Drakenstein Palliative Hospice
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Fonthill Care
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. VITAS Healthcare
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client